JB Chemicals & Pharmaceuticals Limited — Board Meeting, 06-11-2024: Outcome of Board Meeting

J.B. Chemicals & Pharmaceuticals reported its unaudited financial results for Q2 and H1 FY2024. Standalone revenue was ₹95,576 lakhs, yielding a net profit of ₹17,312 lakhs. Consolidated revenue stood at ₹100,062 lakhs, with a net profit of ₹17,457 lakhs. The company's total assets reached ₹394,647 lakhs while equity amounted to ₹315,723 lakhs. The board approved the results, and a review by auditors confirmed compliance with applicable accounting standards.